Cyproterone Acetate/Estradiol Valerate

醋酸环丙孕酮/戊酸雌二醇

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCyproterone Acetate/Estradiol Valerate
Drug Alias Name克龄蒙ClimenSH-461
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor antagonistsEstrogen receptors agonists
TargetsAndrogen ReceptorEstrogen receptors
Therapy Area/IndicationsOestrogen deficiency symptomsVulvar and vaginal atrophyNeurasthenia +[8] 
Global Approved IndicationsOestrogen deficiency symptomsVulvar and vaginal atrophyNeurasthenia +[8] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCzechia
Original Approved Date1993/11/01
Country/TerritoryCzechia
CombinationsYes Estradiol ValerateCyproterone Acetate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsOestrogen deficiency symptomsVulvar and vaginal atrophyNeurasthenia +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeG03CA53
Related LinksN/A